Vienna, Austria

Dieter Scholz

This inventor holds 4 USPTO granted patents and 2 EPO patents. Top assignees: Sandoz Gmbh, Novartis Ag. Active years: 1982-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dieter Scholz. Retrieved from https://idiyas.com/inventor/dieter-scholz-sjvdr78w

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 75.0

 

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1982-2010

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Dieter Scholz: A Pioneer in Pharmaceutical Innovations

Introduction

Dieter Scholz is a notable inventor based in Vienna, Austria, recognized for his contributions to the pharmaceutical field. With a total of four patents to his name, his work primarily focuses on the development of innovative compounds that have potential therapeutic applications in treating proliferative diseases and retroviral infections.

Latest Patents

Dieter’s latest patents showcase his commitment to advancing medical science. One of his notable inventions, related to phenyl-[4-(3-phenyl-1H-pyrazol-4-yl)-pyrimidin-2-yl]-amine derivatives, involves processes for preparing these compounds, which can be utilized for pharmaceutical compositions aimed at treating diseases such as tumors. Another significant patent pertains to 2,4-diamino-3-hydroxycarboxylic acid derivatives, where he highlights compounds that possess interesting pharmacological properties, especially as HIV proteinase inhibitors.

Career Highlights

Throughout his career, Dieter Scholz has made substantial impacts while working with esteemed companies such as Sandoz GmbH and Novartis AG. His innovative spirit and dedication to research have significantly influenced the development of new therapeutic agents that enhance patient care and treatment efficacy.

Collaborations

Dieter has collaborated with several talented individuals, including Andreas Billich and Brigitte Charpiot. These partnerships have propelled his research forward and fostered an environment of innovation that benefits the pharmaceutical industry.

Conclusion

As an inventor, Dieter Scholz exemplifies the spirit of innovation in pharmaceuticals. His dedication to developing new compounds and his ability to collaborate with top professionals in the field continue to drive advancements that may improve treatment options for various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…